Overview

A Study of HR071603(Ketamine Nasal Spray) in Healthy Subjects

Status:
Recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the safety and pharmacokinetics of HR071603 in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Treatments:
Ketamine